Pharmacom Biovet Stock Today
| PHMB Stock | USD 0.0001 0.00 0.00% |
Performance0 of 100
| Odds Of DistressOver 88
|
Pharmacom Biovet is trading at 1.0E-4 as of the 25th of April 2024, a No Change since the beginning of the trading day. The stock's open price was 1.0E-4. Pharmacom Biovet has a very high chance of experiencing financial distress in the next few years of operation. It has also generated negative returns for investors over the last 90 days. Equity ratings for Pharmacom Biovet are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 26th of March 2024 and ending today, the 25th of April 2024. Click here to learn more.
PharmaCom BioVet, Inc. focuses on operating a network of companion animal cancer treatment centers in the United States. PharmaCom BioVet, Inc. was incorporated in 1995 and is headquartered in Raleigh, North Carolina. PHARMACOM BIOVET operates under Medical Care Facilities classification in the United States and is traded on PNK Exchange.. The company has 0 outstanding shares. More on Pharmacom Biovet
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Pharmacom Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Pharmacom Biovet's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Pharmacom Biovet or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
Pharmacom Biovet (PHMB) is traded on OTCCE Exchange in USA and employs 7 people. Pharmacom Biovet is listed under Health Care Providers & Services category by Fama And French industry classification. The company currently falls under 'Nano-Cap' category with a current market capitalization of 10.78 K. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Pharmacom Biovet's market, we take the total number of its shares issued and multiply it by Pharmacom Biovet's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Pharmacom Biovet conducts business under Health Care Providers & Services sector and is part of Health Care industry. The entity has 0 outstanding shares.
Check Pharmacom Biovet Probability Of Bankruptcy
Pharmacom Stock Against Markets
Picking the right benchmark for Pharmacom Biovet stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Pharmacom Biovet stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Pharmacom Biovet is critical whether you are bullish or bearish towards Pharmacom Biovet at a given time. Please also check how Pharmacom Biovet's historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Pharmacom Biovet without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Top Crypto Exchanges Now
Top Crypto ExchangesSearch and analyze digital assets across top global cryptocurrency exchanges |
| All Next | Launch Module |
Pharmacom Biovet Corporate Directors
Pharmacom Biovet corporate directors refer to members of a Pharmacom Biovet board of directors. The board of directors generally takes responsibility for the Pharmacom Biovet's affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Pharmacom Biovet's board members must vote for the resolution. The Pharmacom Biovet board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.| Steve York | VP of Operations and Marketing and Director | Profile | |
| Enzo Vettese | Director | Profile | |
| Ira Frohman | President, Secretary, Treasurer and Director | Profile | |
| Dino Paolucci | VP of D Mecatronics and Director | Profile |
How to buy Pharmacom Stock?
Before investing in Pharmacom Biovet, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Pharmacom Biovet. To buy Pharmacom Biovet stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of Pharmacom Biovet. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase Pharmacom Biovet stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located Pharmacom Biovet stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased Pharmacom Biovet stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Pharmacom Biovet, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. For more information on how to buy Pharmacom Stock please use our How to Invest in Pharmacom Biovet guide.
Already Invested in Pharmacom Biovet?
The danger of trading Pharmacom Biovet is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Pharmacom Biovet is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Pharmacom Biovet. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Pharmacom Biovet is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Pharmacom Biovet offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Pharmacom Biovet's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Pharmacom Biovet Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Pharmacom Biovet Stock: Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Pharmacom Biovet. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population. For information on how to trade Pharmacom Stock refer to our How to Trade Pharmacom Stock guide.You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.
Complementary Tools for Pharmacom Stock analysis
When running Pharmacom Biovet's price analysis, check to measure Pharmacom Biovet's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pharmacom Biovet is operating at the current time. Most of Pharmacom Biovet's value examination focuses on studying past and present price action to predict the probability of Pharmacom Biovet's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pharmacom Biovet's price. Additionally, you may evaluate how the addition of Pharmacom Biovet to your portfolios can decrease your overall portfolio volatility.
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals |
Is Pharmacom Biovet's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Pharmacom Biovet. If investors know Pharmacom will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Pharmacom Biovet listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Pharmacom Biovet is measured differently than its book value, which is the value of Pharmacom that is recorded on the company's balance sheet. Investors also form their own opinion of Pharmacom Biovet's value that differs from its market value or its book value, called intrinsic value, which is Pharmacom Biovet's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Pharmacom Biovet's market value can be influenced by many factors that don't directly affect Pharmacom Biovet's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Pharmacom Biovet's value and its price as these two are different measures arrived at by different means. Investors typically determine if Pharmacom Biovet is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Pharmacom Biovet's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.